GENE ONLINE|News &
Opinion
Blog

Alzheimer's Drug
R&D Alzheimer's Disease
The Latest in Alzheimer’s Research: Restoring Cognitive Function with Nanotech, Gene Therapy, and Enhanced Brain Gamma Oscillations
2024-08-16
Asia-Pacific Alzheimer's DiseaseNeurodegenerative Disease
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
R&D Alzheimer's Disease
Advancements in Alzheimer’s Disease Drug Innovation and Funding Programs in 2024
2024-07-04
Trials & Approvals Alzheimer's DiseaseFDA Approved
FDA Greenlights Eli Lilly’s Groundbreaking Alzheimer’s Drug Kisunla for Early Symptomatic Treatment
2024-07-04
R&D Alzheimer's DiseaseDiagnostic Test
Preventive Medicine for Neurodegeneration on the Rise: New Breakthrough in Routine Blood Testing for Alzheimer’s Disease
2024-05-20
Trials & Approvals Alzheimer's DrugFDA Approval
FDA Granted Eisai and Biogen’s New Alzheimer’s Drug a Traditional Approval, Making Medicare Coverage Possible
2023-07-11
Trials & Approvals Alzheimer's Disease
Eisai and Biogen’s Alzheimer’s Med, Leqembi, Granted FDA Approval
2023-01-09
Trials & Approvals Alzheimer's Disease
Though Alzheimer’s Treatment Fails Presenting Primary Endpoints, TauRx is Still Seeking Approval
2022-10-06
Trials & Approvals Biogen
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Technology Dementia
Alleviating Depression and Dementia with Transcorneal Electrical Stimulation
2022-07-11
Trials & Approvals FDA
Eisai and Biogen’s New Alzheimer’s Drug to Receive FDA Decision by January
2022-07-06
Regulatory Alzheimer's Drug
Eisai to File Another Biogen-Partnered Alzheimer’s Drug After Confidence Hit
2022-05-10
Trials & Approvals Biogen
Biogen Halts Aduhelm’s Second EU Marketing Application
2022-04-25
Regulatory Alzheimer's Drug
CMS’s New Ruling on Biogen’s Aduhelm Restriction Coverage
2022-04-13
Deals South Korea
Alliance Formed: SV Investment and Orange Grove Bio Jointly Source and Develop Novel Medications in the U.S. and Korea
2022-03-16
1 2
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
READ MORE
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top